$555 Million is the total value of Soleus Capital Management, L.P.'s 72 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCAB | BIOATLA INC | $161,639,000 | +49.5% | 3,179,362 | 0.0% | 29.12% | +104.1% | |
| GLTO | GALECTO INC | $9,189,000 | -51.4% | 1,512,648 | 0.0% | 1.66% | -33.7% | |
| MSON | MISONIX INC | $5,903,000 | +56.7% | 301,333 | 0.0% | 1.06% | +114.1% | |
| NEO | NEOGENOMICS INC | $2,216,000 | -10.4% | 45,951 | 0.0% | 0.40% | +22.4% | |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $1,574,000 | -22.7% | 42,743 | 0.0% | 0.28% | +5.6% | |
| OSH | OAK STR HEALTH INC | $1,499,000 | -11.2% | 27,612 | 0.0% | 0.27% | +21.1% | |
| KDMN | KADMON HLDGS INC | $1,309,000 | -6.2% | 336,442 | 0.0% | 0.24% | +28.3% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,285,000 | +2.8% | 500,000 | 0.0% | 0.23% | +40.6% | |
| TRILLIUM THERAPEUTICS INC | $1,115,000 | -27.0% | 103,819 | 0.0% | 0.20% | 0.0% | ||
| RVNC | REVANCE THERAPEUTICS INC | $870,000 | -1.4% | 31,136 | 0.0% | 0.16% | +35.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.